BioCentury
ARTICLE | Financial News

Aldagen amends IPO

December 14, 2009 8:00 AM UTC

Aldagen Inc., Durham, N.C. Business: Gene/Cell therapy Date announced: 12/10/09 Type: IPO To be raised: Up to $80.5 million Price: TBD Shares: TBD Underwriters: Cowen; Wells Fargo; Needham; Boenning &...